GAROFALO, MARIANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.209
AS - Asia 2.872
EU - Europa 1.404
AF - Africa 569
SA - Sud America 459
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 24
Totale 9.593
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.938
SG - Singapore 932
CN - Cina 504
VN - Vietnam 426
IT - Italia 349
BR - Brasile 269
HK - Hong Kong 269
FR - Francia 105
DE - Germania 102
FI - Finlandia 100
IN - India 78
PL - Polonia 69
GB - Regno Unito 59
NL - Olanda 55
RU - Federazione Russa 47
AR - Argentina 46
IQ - Iraq 44
JP - Giappone 36
BD - Bangladesh 34
BJ - Benin 34
ID - Indonesia 34
ES - Italia 30
IR - Iran 30
AT - Austria 29
IE - Irlanda 29
PK - Pakistan 29
ZA - Sudafrica 29
TR - Turchia 28
UA - Ucraina 28
KR - Corea 27
CA - Canada 25
CO - Colombia 24
ET - Etiopia 24
JO - Giordania 24
PH - Filippine 24
SE - Svezia 24
EC - Ecuador 23
EG - Egitto 22
IL - Israele 22
DZ - Algeria 21
JM - Giamaica 21
NZ - Nuova Zelanda 21
SA - Arabia Saudita 21
CH - Svizzera 20
CL - Cile 20
GE - Georgia 20
GN - Guinea 20
MA - Marocco 20
GR - Grecia 19
LB - Libano 19
LU - Lussemburgo 19
NO - Norvegia 19
NP - Nepal 19
PS - Palestinian Territory 19
RO - Romania 19
UZ - Uzbekistan 19
AE - Emirati Arabi Uniti 18
AO - Angola 18
KE - Kenya 18
BO - Bolivia 17
ME - Montenegro 17
MX - Messico 17
PT - Portogallo 17
ZM - Zambia 17
AL - Albania 16
AZ - Azerbaigian 16
BA - Bosnia-Erzegovina 16
CV - Capo Verde 16
DK - Danimarca 16
EE - Estonia 16
MK - Macedonia 16
MR - Mauritania 16
MY - Malesia 16
PY - Paraguay 16
RS - Serbia 16
SI - Slovenia 16
UY - Uruguay 16
YT - Mayotte 16
ZW - Zimbabwe 16
BE - Belgio 15
CI - Costa d'Avorio 15
CR - Costa Rica 15
CZ - Repubblica Ceca 15
GT - Guatemala 15
MD - Moldavia 15
ML - Mali 15
MW - Malawi 15
SN - Senegal 15
TW - Taiwan 15
XK - ???statistics.table.value.countryCode.XK??? 15
AF - Afghanistan, Repubblica islamica di 14
BB - Barbados 14
CU - Cuba 14
CY - Cipro 14
HN - Honduras 14
LC - Santa Lucia 14
LV - Lettonia 14
AD - Andorra 13
BZ - Belize 13
DJ - Gibuti 13
Totale 9.018
Salva come PNG Salva come JPEG
Città #
Ashburn 587
Fairfield 508
Singapore 506
San Jose 472
Hong Kong 227
Seattle 227
Woodbridge 211
Cambridge 177
Houston 173
Ho Chi Minh City 136
Wilmington 136
Chandler 116
Beijing 96
Santa Clara 95
Hanoi 94
Ann Arbor 89
Padova 87
Los Angeles 86
Boardman 83
Helsinki 69
Lauterbourg 58
Council Bluffs 56
San Diego 55
Medford 46
Princeton 45
Chicago 42
Munich 42
Bytom 40
New York 40
Milan 35
Cotonou 32
Hefei 32
São Paulo 30
Des Moines 28
Orem 28
Dong Ket 25
Tokyo 25
Dublin 24
Buffalo 22
Nuremberg 21
Amman 20
Conakry 20
Warsaw 19
Addis Ababa 18
Haiphong 18
Baghdad 17
Guangzhou 17
Lappeenranta 17
Padua 17
Baku 16
London 16
Lusaka 16
Seoul 16
Tbilisi 16
Vienna 16
Bamako 15
Jinan 15
Nairobi 15
Podgorica 15
Tashkent 15
Abidjan 14
Athens 14
Castries 14
Da Nang 14
Dakar 14
Havana 14
Luanda 14
Nouakchott 14
Rio de Janeiro 14
Amsterdam 13
Dushanbe 13
Montevideo 13
Panama City 13
Praia 13
Stockholm 13
Andorra la Vella 12
Bridgetown 12
Frankfurt am Main 12
Harare 12
Lilongwe 12
Ljubljana 12
Redondo Beach 12
Shenyang 12
Vientiane 12
Auckland 11
Bến Tre 11
Kingston 11
Libreville 11
Luxembourg 11
Phnom Penh 11
Roxbury 11
Salt Lake City 11
Shanghai 11
Tallinn 11
Bishkek 10
Cairo 10
Dallas 10
Dar es Salaam 10
Djibouti 10
Johannesburg 10
Totale 5.717
Salva come PNG Salva come JPEG
Nome #
Physical PEGylation to Prevent Insulin Fibrillation 274
Dexamethasone loaded liposomes by thin‐film hydration and microfluidic procedures: Formulation challenges 227
Polymer coated oncolytic adenovirus to selectively target hepatocellular carcinoma cells 222
Oncolytic adenovirus loaded with L-carnosine as novel strategy to enhance the antitumor activity 213
Extracellular vesicles powered cancer immunotherapy: Targeted delivery of adenovirus-based cancer vaccine in humanized melanoma model 209
Thermosensitive "Smart" Surfaces for Biorecognition Based Cell Adhesion and Controlled Detachment 202
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 199
PEG-polyaminoacid based micelles for controlled release of doxorubicin: Rational design, safety and efficacy study 199
Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment 190
Cancer vaccines: an update on recent achievements and prospects for cancer therapy 188
Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma 186
From Immunosuppression to Immunomodulation – Turning Cold Tumours into Hot 183
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma 182
Development of nanovehicles for co-delivery of colistin and ArnT inhibitors 172
Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects 170
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma 170
408. Oncolytic Vaccines in Combination with PD-L1 Blockade for the Treatment of Melanoma 168
PCSK9 promotes arterial medial calcification 168
661. Synergistic Anti-Tumor Efficacy of Immunogenic Adenovirus ONCOS-102 and Standard of Care Chemotherapy in Preclinical Mesothelioma Model 167
Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer 166
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity 163
The evolution of adenoviral vectors through genetic and chemical surface modifications 163
Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model 163
Heterologous and cross-species tropism of cancer-derived extracellular vesicles 161
Screening of chemical linkers for development of pullulan bioconjugates for intravitreal ocular applications 161
Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies 156
Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model 154
The Anti-Proliferative Effect of L-Carnosine Correlates with a Decreased Expression of Hypoxia Inducible Factor 1 alpha in Human Colon Cancer Cells 154
Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation 153
Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice. 153
220. Evaluation of the Efficacy of a New Oncolytic Vaccine Platform in Humanized Mice 151
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks 146
Transplantation of autologous extracellular vesicles for cancer-specific targeting 145
Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2 144
Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform 143
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model 142
71. Boosting the Immunogenicity of an Oncolytic Vaccinia Virus By Expression of DAI Can Enhance Anti-Tumor Immunity in Humanized Mice 141
Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs 140
Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity 139
Unlocking the potential of microfluidic assisted formulation of exenatide-loaded solid lipid nanoparticles 139
From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review 138
622. Oncolytic Adenoviruses Loaded With Active Drugs as a Novel Drug Delivery System for Cancer Therapy 131
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus 129
Molecular Basis of BRAF Inhibitor Resistance in Melanoma: A Systematic Review 128
Isoflavones in aglycone solution enhance ultraviolet B-induced DNA damage repair efficiency 127
Oncolytic adenovirus loaded with L-carnosine as a drug delivery system for cancer therapy 126
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation 123
L-Carnosine and Human Colon Cancer 121
How Computational Chemistry and Drug Delivery Techniques Can Support the Development of New Anticancer Drugs 121
The Multifaceted Roles of Mast Cells in Immune Homeostasis, Infections and Cancers 120
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model 118
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines 118
Erratum: The anti-proliferative effect of L-carnosine correlates with a decreased expression of hypoxia inducible factor 1 alpha in human colon cancer cells (PLoS ONE (2014) 9, 5 (e96755) DOI: 10.1371/journal.pone.0096755) 115
Oncolytic Adenovirus-Based Immunotherapy for Malignant Mesothelioma: Preclinical Advances and Future Perspectives 113
MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy 110
Induction of an immune response by a nonreplicating adenoviruses-based formulation versus a commercial pseudo-SARS-CoV-2 vaccine 97
Application of array-CGH analysis in immune-virotherapy approach 94
In vitro immune evaluation of adenoviral vector-based platform for infectious diseases 87
Localized treatment of glioblastoma: a review of clinical strategies and advances in drug delivery systems 86
I Vaccini 85
L-Carnosine inhibits KRAS-mediated HCT116 proliferation, by affecting ROS production and Hypoxia inducible factor (HIF-1) expression 81
Dynamic 3D microfluidic platform for exploring combined targeted therapy, chemotherapy, and virotherapy delivery in ovarian cancer 76
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 71
Oncologia 71
null 66
Doxorubicin liposomes cell penetration enhancement and its potential drawbacks for the tumor targeting efficiency 55
Development of an in vitro method to assess the immunogenicity of biologics in the prevention of infectious diseases 51
A 3D coculture model of hepatocellular carcinoma: addressing challenges with glycopolymers re-targeted oncolytic viruses 39
FYCO1 Peptide Analogs: Design and Characterization of Autophagy Inhibitors as Co-Adjuvants in Taxane Chemotherapy of Prostate Cancer 25
Redefining long-acting injectables: the emerging role of extracellular vesicles in sustained drug delivery 8
Totale 9.696
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.767
article - articoli 26.679
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 858
Totale 55.304
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 0 86 43
2021/2022663 13 37 76 60 59 27 27 134 80 13 22 115
2022/2023335 73 1 4 23 70 46 1 38 46 3 15 15
2023/2024254 10 44 38 19 9 10 18 17 8 6 46 29
2024/20251.152 9 44 41 51 130 55 71 90 89 49 194 329
2025/20265.711 322 461 926 1.003 464 237 724 450 614 370 140 0
Totale 9.696